0.0150CADMkt Cap: 1.93M CADP/E: —Last update: 2026-05-21
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liqu…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap1.93M CAD
Enterprise Value14.17M CAD
Revenue (TTM)206.31K CAD
Gross Profit206.31K CAD
Net Income (TTM)-2.62M CAD
Revenue/Share0.0020 CAD
Last Price0.0150 CAD
Fiscal Year EndMar 2025
MR QuarterDec 2025
Employees7
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.38
PEG—
EV/EBITDA-2.30
EV/Revenue68.70
P/S9.33
P/B-0.12
EPS (TTM)-0.02
EPS (Forward)-0.04
52W Range
—
52W High0.0150 CAD
52W Low0.0150 CAD
Profitability
Gross Margin100.00%
Oper. Margin-623.85%
EBITDA Margin0.00%
Profit Margin-2613.12%
ROE19.59%
ROA-86.55%
Growth
Revenue Growth6.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF868.82K CAD
CapEx (TTM)2.36K CAD
FCF Margin-1463.19%
FCF Yield-156.78%
Net Debt12.25M CAD
Net Debt/EBITDA-1.99
Balance Sheet
Debt/Equity-0.92
Current Ratio0.03
Quick Ratio0.02
Book Value/Sh-0.1280 CAD
Cash/Share0.0020 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.128.37M
Float114.37M
Insiders0.06%
Institutions10.85%
Short Interest
Short Ratio0.4d
Short % Out.0.01%
Shares Short13.34K
Short (prev mo.)8.30K
Technical
SMA 500.0171 (-12.3%)
SMA 2000.0209 (-28.4%)
Beta-0.30
S&P 52W Chg28.31%
Avg Vol (30d)2.60K
Avg Vol (10d)167.44K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—